| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/23/2003 | US20030017510 Apparatus for use in cell transplantation |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017450 Detection of viral nucleotide sequences in sample; obtain sample, denature, incubate with pimers, hybridize, amplify, expose to probe, detect signal presence indicates viral nucleotide sequences |
| 01/23/2003 | US20030017449 Bacteria detection using immobilized enzyme substrates |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017140 Retroviral vector particles have a chimeric envelope protein consisting of an antigen binding site of an antibody or another peptide, fused to the envelope protein the retroviral vector. |
| 01/23/2003 | CA2453672A1 Root nodule bacteria having enhanced nitrogen-fixation ability |
| 01/22/2003 | EP1277764A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/22/2003 | EP1277464A2 Liposome coated with polyhydroxyalkanoate and production method thereof |
| 01/22/2003 | EP1276907A2 Viral vectors for use in monitoring hiv drug resistance |
| 01/22/2003 | EP1276892A2 A bacterial two-hybrid system for protein interaction screening |
| 01/22/2003 | EP1276852A2 Viruses comprising mutated ion channel protein |
| 01/22/2003 | EP0653067B1 Method and kit for pyridinium crosslink assay |
| 01/22/2003 | EP0627004B1 Improvements in or relating to malaria vaccine |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/22/2003 | CN1099461C Aldehyde dehydrogenase |
| 01/22/2003 | CN1099459C Defoamer for fermentation and process for fermentive production with use of the same |
| 01/21/2003 | US6509514 Chimeric animal model susceptible to human hepatitis C virus infection |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509373 Medium; a method for producing borrelidin utilizing the strain; and the novel uses of borrelidin for fungi |
| 01/21/2003 | US6509185 Provides for a 100-fold increase in the production of a protein from Bacillus subtilis |
| 01/21/2003 | US6509178 Process for preparing docosahexaenoic acid and docosapentaenoic acid with ulkenia |
| 01/21/2003 | US6509177 Cultivating on a medium comprising at least one organic nitrogen or carbon source, in submerged aerated conditions, a Pseudomonas bacterium strain capable of the biosynthesis of pseudomonic acid A |
| 01/21/2003 | US6509176 Heteropolysaccharide produced by an agrobacterium radiobacter |
| 01/21/2003 | US6509159 Methods related to Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 01/21/2003 | US6509156 Efficient homologous recombination mechanism between two DNA molecules occurs at usable frequencies in a bacterial host cell which is capable of expressing the products of the recE and recT genes or functionally related genes |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | CA2234071C Intensive homologous promoter obtained from hamsters |
| 01/21/2003 | CA2130784C Plasmid derived from lactobacillus delbrueckii sp. |
| 01/21/2003 | CA2063592C Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 01/21/2003 | CA1341416C Hirudine variants, their use and preparation process |
| 01/16/2003 | WO2003004666A2 Method for the enantioselective reduction of a prochiral aromatic ketone comprising at least one trifluoromethyl group on the aromatic cycle |
| 01/16/2003 | WO2003004656A1 Method for obtaining cells with new properties |
| 01/16/2003 | WO2003004635A1 Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof |
| 01/16/2003 | WO2003004628A2 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2002070724A3 Method of preparing 2-deoxyribose 5-phosphate |
| 01/16/2003 | WO2002053724A3 Enzymatic deprotection of amines and hydroxides |
| 01/16/2003 | WO2002029030A3 Ethanol production |
| 01/16/2003 | WO2002022080A8 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 01/16/2003 | WO2002006503A3 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013850 Antiinflammatory agents |
| 01/16/2003 | US20030013662 Novel polyketide derivatives and recombinant methods for making same |
| 01/16/2003 | US20030013191 Transgenic cells for use in human therapeutics and diagnostics |
| 01/16/2003 | US20030013180 Pullulanase for use in saccharfication of stsrches |
| 01/16/2003 | US20030013175 Enzymatic polypetide for use in modifying carbohydrates |
| 01/16/2003 | US20030013174 Genes for lysine biosynthetic system derived from thermophilic bacteria |
| 01/16/2003 | US20030013131 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 01/16/2003 | CA2453176A1 Eubacterial host cells devoid of n-terminal formylation and said host cells being useful for the production of proteins and peptides |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2452263A1 Method for the enantioselective reduction of a prochiral aromatic ketone comprising at least one trifluoromethyl group on the aromatic cycle |
| 01/15/2003 | EP1275712A2 Detergents comprising cellulases |
| 01/15/2003 | EP1274997A2 Comparative phenotype analysis for assessment of biologically active compounds |
| 01/15/2003 | EP1274836A1 Lactic acid bacteria overproducing exopolysaccharides |
| 01/15/2003 | EP1274680A1 Synthesis intermediate products for producing vitamin d derivatives |
| 01/15/2003 | EP1274318A1 Cultured protein hydrolysate |
| 01/15/2003 | EP0751986B1 Method for increasing plasmid yield |
| 01/15/2003 | EP0749981B1 Monoclonal antibody specific for pd-ecgf / thymidine phosphorylase |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1391613A Method for preparing conjugated linoleic acid |
| 01/15/2003 | CN1391611A Novel phenol oxidizing enzymes |
| 01/15/2003 | CN1391604A Medium for protein-free and serum-free cultivation of cells |
| 01/15/2003 | CN1391480A Compositions and methods for treatment of allergic disorders |
| 01/14/2003 | US6506962 Disease resistance |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506879 Endotoxin-free; genetically expressed in bacteria; atherosclerosis and cardiovascular disorder treatment |
| 01/14/2003 | US6506598 Gene expression of tissue plasminogen activator in butyrate salt |
| 01/14/2003 | US6506591 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 01/14/2003 | US6506590 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 01/14/2003 | US6506589 Useful mutations of bacterial alkaline protease |
| 01/14/2003 | US6506583 Culturing in glycerol, fructose, sorbose, mannitol, sorbitol, inositol, or glucose; fermentation; isolating nontoxic lipopolysaccharide produced by mutant |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506566 Screening enzymatic polypeptides for use in detergents; obtain microorganism expressing polypeptides, incubate with detergent, expose to binding protein, separate bound complex, isolate and propagate genome coding enzymatic variant |
| 01/14/2003 | US6506560 Cloned DNA polymerases from Thermotoga and mutants thereof |
| 01/14/2003 | US6506431 Spore germination inhibitor and food containing the same |
| 01/14/2003 | US6506388 Treating pollinosis using substance obtained by dissolving cell wall of corynebacterlum glutamicum with one of glucosi-dase and endopeptidase in isotonic solution medium, separa-ting protoplasts and treating with the other enzyme |
| 01/14/2003 | US6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/14/2003 | CA2027355C Yeast promoter |
| 01/09/2003 | WO2002008428A3 Production of polyhydroxyalkanoates from polyols |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008390 Genetically engineered cell for use in the generation of viral vector for use in gene therapy |
| 01/09/2003 | US20030008367 Isolation and purification of clostridium botulinum toxins |
| 01/09/2003 | US20030008366 Polypeptide for use in the treatment of inflammation |
| 01/09/2003 | US20030008360 Microorganisms for use in the generation of preferential cyclopentene |
| 01/09/2003 | US20030008358 Method of producing L-serine by fermentation |
| 01/09/2003 | US20030008337 Analytical system based upon spore germination |
| 01/09/2003 | US20030007980 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/2003 | EP1273665A1 Process for the production of optically active beta-amino alcohols |
| 01/08/2003 | EP1273593A1 Isolation and purification of clostridium botulinum toxins |
| 01/08/2003 | EP1272669A1 High-throughput screening of expressed dna libraries in filamentous fungi |
| 01/08/2003 | EP1272658A1 Bacteria and bacteriophage detection using immobilized enzyme substrates |
| 01/08/2003 | EP1272653A2 Methods for ansamitocin production |
| 01/08/2003 | EP1272624A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 01/08/2003 | EP1272623A2 Novel subtilase enzymes having an improved wash performance on egg stains |